S

Signatope GmbH

8 employees

SIGNATOPE develops the next generation of protein biomarker assays using a special type of immunoaffinity based mass spectrometry assays.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Clinical Trials

Date founded

2016

Funding rounds raised

Total raised

$672K

from 1 investors over 1 rounds

S

Signatope GmbH raised $672K on May 26, 2017

Investors: High-Tech Gründerfonds

FAQ